Issue 54, 2022

Self-assembled benzoselenadiazole-capped tripeptide hydrogels with inherent in vitro anti-cancer and anti-inflammatory activity

Abstract

Self-assembled benzoselenadiazole (BSe)-capped tripeptide based nanofibrillar hydrogels have been developed with inherent anticancer and anti-inflammatory activity.

Graphical abstract: Self-assembled benzoselenadiazole-capped tripeptide hydrogels with inherent in vitro anti-cancer and anti-inflammatory activity

Supplementary files

Article information

Article type
Communication
Submitted
25 feb 2022
Accepted
07 jún 2022
First published
07 jún 2022

Chem. Commun., 2022,58, 7534-7537

Self-assembled benzoselenadiazole-capped tripeptide hydrogels with inherent in vitro anti-cancer and anti-inflammatory activity

T. Ghosh, S. Wang, D. Kashyap, R. G. Jadhav, T. Rit, H. C. Jha, B. G. Cousins and A. K. Das, Chem. Commun., 2022, 58, 7534 DOI: 10.1039/D2CC01160C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements